Abstract
Odds ratios were not significantly different by gender, age, or education years. Frequency of use was low, with a mean of 5.4 times/year. Conclusions: A clinically significant proportion of treatment seeking substance users reported infrequent synthetic cannbinoid use. Less than full-time employment and Black race may be risk factors for use; marijuana smoking did not appear to increase risk. Asking about use can identify patients who may benefit from continued monitoring, however more extensive toxicology screening is not supported. Financial Support: Supported by: National Institutes on Drug Abuse (DA009236), National Institutes on Drug Abuse (T32DA007294-19).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
